IINN — Inspira Technologies Oxy BHN Cashflow Statement
0.000.00%
HealthcareMicro Cap
- $31.52m
- $29.39m
Annual cashflow statement for Inspira Technologies Oxy BHN, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.23 | -17.2 | -15 | -11.3 | -11.1 |
| Depreciation | |||||
| Non-Cash Items | 4.8 | 10.7 | 4.77 | 1.39 | 1.94 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.348 | -0.215 | 0.504 | 0.034 | -0.432 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Cash from Operating Activities | -1.88 | -6.68 | -9.65 | -9.76 | -9.37 |
| Capital Expenditures | -0.023 | -0.182 | -0.263 | -0.206 | -0.164 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.003 | 0 | -7.12 | 4.8 | 1.65 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.026 | -0.182 | -7.38 | 4.59 | 1.49 |
| Financing Cash Flow Items | — | 0 | 0 | -0.454 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.29 | 30.2 | 0 | 3.45 | 7.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.4 | 23.3 | -17 | -1.71 | 0.071 |